angelMD Catalyst I, LP is a private investment fund based in Seattle, Washington. According to its most recent Form D, filed Jul 19, 2018, it has sold $3,100,000 of interests to 21 investors since its first sale in Aug 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include LLC Assure Fund Management II; LLC angelMD Catalyst Management; Richard Thoms.
- Total raised
- $3,100,000Cumulative sales reported on Form D
- Investors
- 21
- First sale
- Aug 18, 2017
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- LLC Assure Fund Management II; LLC angelMD Catalyst Management; Richard Thoms
- Latest Form D
- Jul 19, 2018
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about angelMD Catalyst I, LP
What is the minimum investment for angelMD Catalyst I, LP?
angelMD Catalyst I, LP's latest Form D, filed Jul 19, 2018, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in angelMD Catalyst I, LP?
angelMD Catalyst I, LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has angelMD Catalyst I, LP raised?
angelMD Catalyst I, LP reports $3,100,000 sold from 21 investors on its Form D filed Jul 19, 2018. This is cumulative sales since the offering began, not current assets or performance.
Where is angelMD Catalyst I, LP based?
angelMD Catalyst I, LP is based in Seattle, Washington.
When did angelMD Catalyst I, LP launch?
angelMD Catalyst I, LP reports its first sale in Aug 2017.
Size compared with every private investment fund
Raised more than 35% of the 114 private investment funds based in Washington, and more than 26% of all 10,287 that report sales.